AiCure
AI-powered patient engagement platform for clinical trials using computer vision and predictive analytics
4 views this month
About
AiCure is a specialized AI company that provides patient engagement solutions for clinical trials through its flagship platform, H.Code. The platform leverages AI-powered computer vision, synchronous chat, and predictive analytics to monitor and support trial participants through their smartphones, enabling remote patient monitoring and adherence tracking.
The company's H.Code platform offers comprehensive features including medication adherence monitoring, eCOA-ePRO data capture, and predictive analytics to identify early termination risks. AiCure has demonstrated significant impact in clinical research, achieving 92% participant retention rates and reducing dropout rates by more than half across over 2,200 clinical trial sites spanning 46 countries and 45 languages.
With over 14 years of experience and 84 awarded patents, AiCure serves 7 of the top 10 global pharmaceutical companies, having captured over 1.5 million participant doses across various clinical trial models including traditional site-based, decentralized, fully virtual, and hybrid approaches.
The company's H.Code platform offers comprehensive features including medication adherence monitoring, eCOA-ePRO data capture, and predictive analytics to identify early termination risks. AiCure has demonstrated significant impact in clinical research, achieving 92% participant retention rates and reducing dropout rates by more than half across over 2,200 clinical trial sites spanning 46 countries and 45 languages.
With over 14 years of experience and 84 awarded patents, AiCure serves 7 of the top 10 global pharmaceutical companies, having captured over 1.5 million participant doses across various clinical trial models including traditional site-based, decentralized, fully virtual, and hybrid approaches.
Related Vendors
Last updated 1 day ago